Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2025)

ENDRA Life Sciences has reported Income from Continuing Operations over the past 6 years, most recently at 3104628.0 for Q4 2021.

  • Quarterly Income from Continuing Operations fell 37.94% to 3104628.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 11231250.0 through Dec 2021, up 4.22% year-over-year, with the annual reading at 7027410.0 for FY2025, 38.93% up from the prior year.
  • Income from Continuing Operations was 3104628.0 for Q4 2021 at ENDRA Life Sciences, down from 2658242.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 741623.0 in Q1 2017 and troughed at 4809294.0 in Q4 2019.
  • The 5-year median for Income from Continuing Operations is 2703489.0 (2019), against an average of 2571796.85.
  • Year-over-year, Income from Continuing Operations plummeted 280.96% in 2018 and then soared 53.2% in 2020.
  • A 5-year view of Income from Continuing Operations shows it stood at 2294640.0 in 2017, then decreased by 3.09% to 2365610.0 in 2018, then crashed by 103.3% to 4809294.0 in 2019, then soared by 53.2% to 2250761.0 in 2020, then tumbled by 37.94% to 3104628.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Income from Continuing Operations are 3104628.0 (Q4 2021), 2658242.0 (Q3 2021), and 3199104.0 (Q2 2021).